GlaxoSmithKline, the biggest drugmaker in the Triangle, generated about a billion less in U.S. sales in the first quarter, largely because it hasn’t been able to bring enough products to market to replace sales lost to generic competitors.
SITT bloggers and journalists share observations, ideas and opinions about the Research Triangle Park region. Contributors include Ross Maloney, Sabine Volmer, DeLene Beeland and Bora Zivkovic, as well as members of the Science Communicators of North Carolina (SCONC). Our intended audience members are researchers, scientists, students, businesses, residents and the otherwise science-curious of our region.
Science in the Triangle is a community service provided by the Research Triangle Park and Blue Pane Studio, in partnership with Museum of Life + Science.
© 2008-2009, All Rights Reserved.
